Stine is a postdoctoral fellow working within the behavioural and epidemiology research core of the Canadian Network on Hepatitis C. Her research interests center broadly upon understanding how structural and environmental forces shape behaviour, opportunity, and health, and employing innovative methods in research design and analysis to answer these questions.

Sahar Bajis is a PhD Scholar at the Kirby Institute, University of New South Wales Sydney. She holds a master's degree in International Public Health and has extensive experience as a clinical pharmacist and in the field of international humanitarian aid.

Alisa Pedrana is public health practitioner and Research Fellow at Burnet Institute. Her research career to date has focussed on BBBV/STI epidemiology and surveillance to inform prevention practice and policy with a particular interest in implementation science to strengthen health system and enhance health service delivery.

ZM is a PhD Clinical Research Fellow at Imperial College London. He work is focused on assessing and improving the HCV care continuum in marginalised populations, which includes projects in a London prison as well as PWID in Tanzania.

Marie Francis is a nurse with extensive clinical, research and health policy experience. Practice to date has included working in diverse areas, from critical care to outreach nursing-aimed at engaging hard to reach groups. After gaining a Master’s degree in Public Health at King’s College London in 2012, she has worked for the National Institute for Health and Care Excellence (NICE), Imperial College London and is currently a research nurse at the institute for Global Health, University College London.

PI to the HepCare project - funded by the European Commission Third Health Programme and research nurse at the Institute of Global Health, University College London, UK

Elisa Martró leads the Research Group on Clinical Virology and New Diagnostic Approaches at IGTP (Barcelona, Spain). Her research is currenly focussed on improving the diagnosis of hepatitis C virus in hard-to-reach groups through novel molecular assays and screening strategies, and in molecular epidemiology studies with public health impact.

Rob Bielen has started his training in Internal Medicine in 2013 at KULeuven in Belgium, and since 2015, he has started his PhD concerning screening, linkage to care and uptake for treatment for HCV, both in PWID and the general population.